Bayer Animal Health Helps Swine Producers Feed the World
3 Pages
English

Bayer Animal Health Helps Swine Producers Feed the World

Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

Bayer Animal Health Helps Swine Producers Feed the World PR Newswire JEJU, South Korea, June 10, 2012 JEJU, South Korea, June 10, 2012 /PRNewswire/ -- - Leading animal health company puts future of swine production on top of agenda at pivotal meeting Bayer Animal Health used the occasion of the 22nd International Pig Veterinary Society (IPVS) Congress in Jeju, South Korea, to reveal the latest programme of activities aimed at transforming livestock production. As part of their commitment to the advancement of knowledge in the livestock community, Bayer Animal Health held the 4th International Bayer Pig Symposium in Jeju on June 10th, giving more than 200 veterinarians and swine producers from 19 countries access to the latest thinking on practical solutions to the problems raised by global changes. This was followed by a Satellite Symposium at the IPVS Congress with leading academic figures debating the future of swine production in a world of increasing consumption and decreasing natural resources. Wolfgang Müller, Head of Global Marketing Farm Animal Products at Bayer Animal Health said "At Bayer Animal Health, we are acutely aware of the challenges facing the pig industry in the years to come: the need to deliver increased productivity in a cost-effective manner while preserving resources and protecting animal health and welfare are key issues. All parts of livestock community need to work together to meet these challenges.

Subjects

Informations

Published by
Reads 10
Language English
Bayer Animal Health Helps Swine Producers
Feed the World
PR Newswire
JEJU, South Korea, June 10, 2012
JEJU,
South Korea
,
June 10, 2012
/PRNewswire/ --
- Leading animal health company puts future of swine
production on top of agenda at pivotal meeting
Bayer Animal Health used the occasion of the 22nd International Pig Veterinary
Society (IPVS) Congress in Jeju,
South Korea
, to reveal the latest programme of
activities aimed at transforming livestock production.
As part of their commitment to the advancement of knowledge in the livestock
community, Bayer Animal Health held the 4th International Bayer Pig
Symposium in Jeju on
June 10th
, giving more than 200 veterinarians and swine
producers from 19 countries access to the latest thinking on practical solutions
to the problems raised by global changes. This was followed by a Satellite
Symposium at the IPVS Congress with leading academic figures debating the
future of swine production in a world of increasing consumption and decreasing
natural resources.
Wolfgang Müller, Head of Global Marketing Farm Animal Products at Bayer
Animal Health said "At Bayer Animal Health, we are acutely aware of the
challenges facing the pig industry in the years to come: the need to deliver
increased productivity in a cost-effective manner while preserving resources
and protecting animal health and welfare are key issues. All parts of livestock
community need to work together to meet these challenges. With these
symposia and other events of their kind, we will continue to bring together local
knowledge, science, innovation and global expertise to help the livestock
community to survive and thrive in these challenging times."
Sharing local knowledge
The 4th International Bayer Pig Symposium, chaired by Dr Bent Nielsen,
Representative of the Swine Veterinary Association of
Denmark
, focused on
sharing local knowledge to deliver practical guidance for swine producers and
vets seeking to improve swine welfare and production now and for the future.
The Symposium was opened by Dr Kees Scheepens from FarmulaOne in
the
Netherlands
, who took the audience through the basics of the new Pig Signals
®
concept whilst Dr Joaquim Segalés from the Universitat Autònoma de
Barcelona, Spain
presented practical tips for designing swine vaccination
programmes that maximise results while minimizing costs. Dr Kyoungjin Kim of
the Pig and Health Vet Group in
South Korea
gave an update on the current
state of Porcine Epidemic Diarrhoea (PED) in
South Korea
, showing mortality
rates in suckling pigs were up to 100%. According to Dr Kim, a new trend is
being seen in PED infections in
South Korea
, with lower rates of mortality (20-
30% versus 80-100%) appearing in suckling piglets in the 2011/12 winter
season. However Dr Kim stressed that prevention is key to controlling PED, with
those applying bio-security concepts seeing reduced numbers of outbreaks.
Finally, Dr Anders Holm of the Odder Veterinary Practice in
Denmark
took the
audience through his efforts to raise awareness of coccidiosis infection in
China
with a 'lab-on-wheels', developed by Bayer Animal Health. Dr Holm toured
China
giving swine producers previously unattainable access to laboratory
facilities to assess the presence of coccidiosis on their farms. According to Dr
Holm, "Pig producers in
China
are very interested in exchanging experiences
with colleagues from abroad. I also believe that European producers could
learn from Chinese colleagues, as costs of buildings are reduced and diseases
not yet present in
Europe
are frequent in
China
."
'Feeding the world…or saving the planet?
At the Satellite Symposium on
June 11th
, the need for practical guidance on
maximising production value was debated by 400 veterinarians and swine
producers from around the world. Entitled 'Feeding the world…or saving the
planet?' the lively debate was chaired by Professor Arlette Laval, Professor of
Food Animal Medicine at Nantes Atlantic College of Veterinary Medicine.
The debate gave insights into the challenges and opportunities facing swine
production as population growth continues along with meat consumption levels.
Dr Osler Desouzart, owner of OD consulting in
Brazil
, presented the case for
science and technology delivering a 'Silent Green Revolution' to address the
inequalities in access to quality meat proteins.
Dr Desouzart said, "The world population is forecast to continue to grow until at
least 2100, but with growth focussed in the least developed areas of the planet,
fair distribution of food availability will become critical."
Dr Manfred J Kern from agriExcellence GmbH in
Germany
, examined the need
to balance environmental impact with large-scale pig production. According to
Dr Kern, the greatest challenge being faced by the livestock sector will be in
finding ways to minimise greenhouse gas emissions and develop a new form of
'carbon conscious pork' with a dramatically lower carbon footprint. "Veterinary
medicines will play a key role, not only in ensuring that we can keep pigs
healthy and thriving, but also in helping to safeguard resources by minimising
losses to disease or pandemics" said Dr Kern.
Vaccine hope for Classical Swine Fever
Bayer Animal Health also took the opportunity to present further information on
the development of their new vaccine for Classical Swine Fever (CSF). Posters
presented by Dr Maw-Shen of the National Chung Hsing University of
Taiwan
,
demonstrated positive efficacy results and prevention of horizontal
transmission of CSF.
Transforming Livestock Production
"Our activities around IPVS are a great example of our Transforming Livestock
Production commitment in action. We feel that all those who attended our
events have taken away a greater understanding of the future challenges they
will face, but with credible, concrete guidance on what they can do to step up
and meet these challenges: letting them know that we are partners in this
journey" said Wolfgang Müller.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of
health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of
Bayer AG with annual sales of
EUR 17.2 billion
(2011), is one of the world's
leading, innovative companies in the healthcare and medical products industry
and is based in Leverkusen,
Germany
. The company combines the global
activities of the Animal Health, Consumer Care, Medical Care and
Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop,
manufacture and market products that will improve human and animal health
worldwide. Bayer HealthCare has a global workforce of 55,700 employees (
Dec
31, 2011
) and is represented in more than 100 countries. Find more
information at http://www.bayerhealthcare.com.
With a turnover of EUR 1.190 million (2011) Bayer HealthCare's Animal Health
Division is one of the world's leading manufacturers of veterinary drugs. The
division manufactures and markets more than 100 different veterinary drugs
and care products for livestock and companion animals.
Forward-Looking Statements
This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.
These factors include those discussed in Bayer's public reports which are
available on the Bayer website at http://www.bayer.com. The company
assumes no liability whatsoever to update these forward-looking statements or
to conform them to future events or developments.